Income Statement | | | | | | | | | | | | |
| | | | | | | | | | | | Original |
CAD | Fiscal Year Ending | | Latest |
(in millions) | Dec-14 | Dec-15 | Dec-16 | Dec-17 | Dec-18 | Dec-19 | Dec-20 | Dec-21 | Dec-22 | Dec-23 | | Sep-24 |
| FY - 9 | FY - 8 | FY - 7 | FY - 6 | FY - 5 | FY - 4 | FY - 3 | FY - 2 | FY - 1 | FY | | LTM |
| | | | | | | | | | | | |
Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | | 1 |
% Growth | NA | -71.3% | -54.8% | 5.4% | 219.3% | -3.3% | -100.0% | NA | 211.6% | 3.7% | | |
| | | | | | | | | | | | |
Cost of Revenue | (0) | (0) | (0) | (0) | (0) | (0) | 0 | 0 | 0 | 0 | | 0 |
Gross Profit | (0) | (0) | (0) | (0) | (0) | (0) | 0 | 0 | 1 | 1 | | 1 |
% Revenue | -9.4% | -72.4% | -214.0% | -158.7% | -11.4% | -16.2% | NA | 100.0% | 100.0% | 100.0% | | 100.0% |
| | | | | | | | | | | | |
Research and Development | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Selling and Marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
General and Admin | (1) | (1) | (1) | (1) | (1) | (0) | (0) | (1) | (1) | (1) | | (1) |
Other Inc / (Exp) | (0) | (1) | (0) | (0) | (0) | (0) | (2) | (1) | (0) | (1) | | (1) |
Total Operating Exp | (1) | (2) | (1) | (1) | (1) | (1) | (2) | (2) | (1) | (2) | | (2) |
| | | | | | | | | | | | |
Operating Income | (1) | (2) | (1) | (1) | (1) | (1) | (2) | (2) | (0) | (1) | | (1) |
% Revenue | -360.1% | -1548.2% | -2226.0% | -1492.5% | -489.4% | -372.1% | NA | -817.4% | -73.3% | -151.1% | | -161.1% |
| | | | | | | | | | | | |
Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | (0) | 0 | (0) | | (0) |
Pre-tax Income | (1) | (1) | (1) | (1) | (1) | (0) | (2) | (2) | (0) | (1) | | (1) |
Earnings of Discontinued Ops. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Provision for Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | (0) | 0 | | 0 |
Net Income to Company | (1) | (1) | (1) | (1) | (1) | (0) | (2) | (2) | (1) | (1) | | (1) |
% Margin | -345.1% | -1427.5% | -1962.7% | -1266.3% | -422.8% | -294.2% | NA | -820.6% | -76.9% | -151.6% | | -162.2% |
| | | | | | | | | | | | |
Minority Interest in Earnings | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Net Income to Stockholders | (1) | (1) | (1) | (1) | (1) | (0) | (2) | (2) | (1) | (1) | | (1) |
| | | | | | | | | | | | |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Other Adj. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
| | | | | | | | | | | | |
Net Income to Common | (1) | (1) | (1) | (1) | (1) | (0) | (2) | (2) | (1) | (1) | | (1) |
% Margin | -345.1% | -1427.5% | -1962.7% | -1266.3% | -422.8% | -294.2% | NA | -820.6% | -76.9% | -151.6% | | -162.2% |
| | | | | | | | | | | | |
As Reported | | | | | | | | | | | | |
Basic EPS (Continuing Ops) | (0.01) | (0.01) | (0.00) | (0.00) | (0.00) | (0.00) | (0.01) | (0.01) | (0.00) | (0.00) | | (0.00) |
Diluted EPS (Continuing Ops) | (0.01) | (0.01) | (0.00) | (0.00) | (0.00) | (0.00) | (0.01) | (0.01) | (0.00) | (0.00) | | (0.00) |
| | | | | | | | | | | | |
WA Basic Shares Out. | 217.36 | 289.68 | 289.68 | 289.68 | 289.68 | 289.68 | 289.68 | 289.68 | 289.68 | 289.68 | | 289.68 |
WA Diluted Shares Out. | 217.36 | 289.68 | 289.68 | 289.68 | 289.68 | 289.68 | 289.68 | 289.68 | 289.68 | 289.68 | | 289.68 |
| | | | | | | | | | | | |
EBITDA, EBIT Reconciliation | | | | | | | | | | | | |
EBT, Incl. Unusual Items | (1) | (1) | (1) | (1) | (1) | (0) | (2) | (2) | (0) | (1) | | (1) |
Addback: Net Interest Expense | (0) | (0) | (0) | (0) | (0) | (0) | (0) | 0 | (0) | 0 | | 0 |
Addback: Other Non Operating Expenses, Total | 0 | 0 | 0 | 0 | 0 | 0 | 0 | (0) | (0) | 0 | | (0) |
Addback: Depreciation & Amortization | 0 | 1 | 0 | 0 | 0 | 0 | 2 | 1 | 0 | 1 | | 1 |
Addback: Restructuring Charges | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Merger / Acquisition Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Goodwill Impairment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Gain (Loss) On Sale Of Invest. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Gain (Loss) On Sale Of Assets | 0 | 0 | (0) | 0 | 0 | 0 | 2 | 1 | 0 | 1 | | 1 |
Addback: Asset Writedown | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: In Process R&D Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Insurance Settlements | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Legal Settlements | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Other Unusual Items | 0 | 0 | 0 | 0 | 0 | 0 | 0 | (0) | 0 | (0) | | (0) |
Adjusted EBITDA | (1) | (1) | (1) | (1) | (1) | (1) | 1 | 1 | 0 | 0 | | 0 |
% Margin | -275.5% | -1035.6% | -2056.9% | -1405.8% | -449.2% | -335.3% | NA | 271.4% | 40.8% | 42.7% | | 23.4% |
| | | | | | | | | | | | |
Adjusted EBIT | (1) | (2) | (1) | (1) | (1) | (1) | (0) | (1) | (0) | (0) | | (0) |
% Margin | -360.1% | -1548.2% | -2596.6% | -1492.5% | -489.4% | -372.1% | NA | -325.9% | -17.8% | -47.3% | | -72.1% |
| | | | | | | | | | | | |
Adjusted Net Income Reconciliation | | | | | | | | | | | | |
Net Income to Company | (1) | (1) | (1) | (1) | (1) | (0) | (2) | (2) | (1) | (1) | | (1) |
Addback: Unusual Items | 0 | 0 | (0) | 0 | 0 | 0 | 2 | 1 | 0 | 1 | | 1 |
Less: Tax Benefit of Unusual Items (26%) | 0 | 0 | 0 | 0 | 0 | 0 | (0) | (0) | (0) | (0) | | (0) |
Adjusted Net Income | (1) | (1) | (1) | (1) | (1) | (0) | (1) | (1) | (0) | (1) | | (1) |
% Margin | -345.1% | -1427.5% | -2236.9% | -1266.3% | -422.8% | -294.2% | NA | -433.0% | -35.8% | -75.5% | | -95.7% |